4.6 Article

Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Respiratory Failure*

期刊

CRITICAL CARE MEDICINE
卷 49, 期 7, 页码 1026-1037

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CCM.0000000000004938

关键词

adult; coronavirus disease 2019; intensive care units; prone position; respiratory distress syndrome; respiratory insufficiency

资金

  1. National Institute of Health (NIH)
  2. National Heart, Lung, and Blood Institute (NHLBI)
  3. NIH
  4. National Institute on Aging
  5. National Institute of General Medical Sciences
  6. RenalytixAI
  7. Relypsa
  8. Takeda Pharmaceuticals
  9. CHF Solutions
  10. Bayer
  11. Boehringer Ingelheim
  12. Akebia
  13. inRegen
  14. Renal Research Institute
  15. XORTX Therapeutics, Inc.
  16. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  17. NIDDK
  18. Horizon Therapeutics PLC
  19. AstraZeneca
  20. Tate Latham
  21. CVS Caremark
  22. NHLBI
  23. BioPorto
  24. Gerson Lehrman Group

向作者/读者索取更多资源

Early proning initiation is associated with lower mortality risk in hypoxemic patients with coronavirus disease 2019, compared to those who did not receive early proning.
OBJECTIVES: Therapies for patients with respiratory failure from coronavirus disease 2019 are urgently needed. Early implementation of prone positioning ventilation improves survival in patients with acute respiratory distress syndrome, but studies examining the effect of proning on survival in patients with coronavirus disease 2019 are lacking. Our objective was to estimate the effect of early proning initiation on survival in patients with coronavirus disease 2019-associated respiratory failure. DESIGN: Data were derived from the Study of the Treatment and Outcomes in Critically Ill Patients with coronavirus disease 2019, a multicenter cohort study of critically ill adults with coronavirus disease 2019 admitted to 68 U.S. hospitals. Using these data, we emulated a target trial of prone positioning ventilation by categorizing mechanically ventilated hypoxemic (ratio of Pao(2) over the corresponding Fio(2) <= 200 mm Hg) patients as having been initiated on proning or not within 2 days of ICU admission. We fit an inverse probability-weighted Cox model to estimate the mortality hazard ratio for early proning versus no early proning. Patients were followed until death, hospital discharge, or end of follow-up. SETTING: ICUs at 68 U.S. sites PATIENTS: Critically ill adults with laboratory-confirmed coronavirus disease 2019 receiving invasive mechanical ventilation with ratio of Pao(2) over the corresponding Fio(2) less than or equal to 200 mm Hg. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among 2,338 eligible patients, 702 (30.0%) were proned within the first 2 days of ICU admission. After inverse probability weighting, baseline and severity of illness characteristics were well-balanced between groups. A total of 1,017 (43.5%) of the 2,338 patients were discharged alive, 1,101 (47.1%) died, and 220 (9.4%) were still hospitalized at last follow-up. Patients proned within the first 2 days of ICU admission had a lower adjusted risk of death compared with nonproned patients (hazard ratio, 0.84; 95% CI, 0.73-0.97). CONCLUSIONS: In-hospital mortality was lower in mechanically ventilated hypoxemic patients with coronavirus disease 2019 treated with early proning compared with patients whose treatment did not include early proning.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据